After prostate surgery very few men are the same as before
Thursday, September 30th, 2010 Posted in prostatectomy | No Comments »After a prostatectomy there are very few men who are the same as before. The effects of surgery can range from mild loss of erection and pain on orgasm, to total loss of erection and incontinence. The good news is that ...
Set of biomarkers that can distinguish prostate cancer
Wednesday, September 29th, 2010 Posted in prostate cancer diagnosis | No Comments »Researchers from Oxford Gene Technology (OGT) and its subsidiary, Sense Proteomic, Ltd., England, say they have discovered a set of biomarkers that can distinguish prostate cancer from benign prostate disease and healthy tissue with 90 percent accuracy. This preliminary data, if ...
HIFU under clinical trials
Tuesday, September 28th, 2010 Posted in hifu | No Comments »Because it doesn't harm the rest of the prostate, HIFU (High Intensity Focused Ultrasound) has fewer side effects than standard treatments like surgery and radiation. Right now clinical trials for HIFU are for patients whose prostate cancer has come back. But ...
Surgery found effective for patients with aggressive prostate cancer
Monday, September 27th, 2010 Posted in hormone therapy, prostatectomy, radiation therapy | No Comments »In the largest, most modern, single-institution study of its kind, Mayo Clinic urologists mined a long-term data registry for survival rates of patients who underwent radical prostatectomy for localized prostate cancer. Radical prostatectomy was the primary treatment for the men. Studies ...
Cancer patients need more information
Sunday, September 26th, 2010 Posted in prostate cancer | No Comments »While there are excellent methods to diagnose and treat prostate cancer, doctors need to provide their patients with the best current information possible to allow them to make an appropriate and informed decision regarding treatment. Currently, men with localized cancer can ...
Results of custirsen Phase 2 trial for advanced prostate cancer
Saturday, September 25th, 2010 Posted in prostate cancer | No Comments »OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) published today results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The study ...
Prostate cancer risk and exposure to pesticides
Thursday, September 23rd, 2010 Posted in prostate cancer risks | No Comments »A recent study at BC Cancer Agency, Vancouver, British Columbia, Canada, aimed to assess the risk of developing prostate cancer in relation to exposure to specific active compounds in pesticides. Researchers observed a significant excess risk for several active ingredients that ...
Cholesterol drug may have role in treating prostate cancer
Wednesday, September 22nd, 2010 Posted in prostate cancer | No Comments »According to new research by at St. Michael's Hospital, a drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer. Rosuvastatin—a statin drug sold as Crestor—suppressed the growth of transplanted human prostate cancer cells in ...
Recommendations for prostate cancer prevention and treatment
Tuesday, September 21st, 2010 Posted in prostate cancer | No Comments »In light of Prostate Cancer Awareness month, Columbia University recently published recommendations for the prevention and treatment of prostate cancer. The recommendations strategically combine ancient and modern healing modalities into a holistic practice of medicine by successfully incorporating the most ...
Blood test accurately predicts death from prostate cancer up To 25 years in advance
Saturday, September 18th, 2010 Posted in prostate cancer risks | No Comments »According to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden, a blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next ...